FDA approves diabetes drug Victoza but orders safety studies

01/25/2010 | Wall Street Journal, The

The FDA approved Victoza, a Type 2 diabetes drug from Novo Nordisk, with an order that the Danish firm conduct additional safety studies of the product. The studies would focus on a possible association between Victoza, or liraglutide, and a heightened risk of medullary thyroid cancer and other related diseases.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR